Regular exercise reduced the risk of dying by 29% to 36%, and increased physical activity in midlife was as effective as maintaining a high activity level from adolescence onward. Medscape Medical News …read more
For use in advanced triple-negative disease, atezolizumab is approved in combination with the chemotherapy nab-paclitaxel. The pairing improved progression-free survival. FDA Approvals …read more
Because of its toxicity, chemotherapy is an occupational hazard for the staff of cancer clinics, but related safety issues do not seem to be a major clinical concern or a topic of much research. Medscape Medical News …read more
Newborns of women with insulin-treated diabetes have the highest risk for being large for gestational age and prematurity; maternal type 2 diabetes increases these risks, and maternal obesity adds to it. Medscape Medical News …read more